Flight Microangiopathy on Long-Haul Flights: Prevention of Edema and Microcirculation Alterations with Venoruton

Abstract

The aim of this study was the evaluation of the effects of Venoruton (HR) on the prevention and control of flight microangiopathy and edema in subjects with varicose veins flying for more than 7 hours. A group of 80 patients with varicose veins, edema, and initial skin alterations due to chronic venous hypertension were included. Measurements of skin laser Doppler (LDF) resting flux (RF), Po₂ and rate of ankle swelling (RAS), were made before and after the flights (within 2 hours before the flights and within 2 hours after the flights). The length of the flights was between 7 and 9 hours; all seats were in coach class. The two groups (treatment and control) were comparable for age and sex distribution. The variation (decrease) in PO₂ was significant in both groups. In subjects treated with HR the decrease in Po₂ was smaller (p<0.05). The decrease in LDF-RF was significant in both groups with a higher flux at the end of the flight in the treated subjects (p<0.05). The venoarteriolar response was decreased at the end of the flights. The decrease was less evident in the treatment group (p<0.05). The increase in RAS was significant in the control group while it was limited in the HR group. In conclusion, HR is useful for reducing the increased capillary filtration and in controlling edema in patients with chronic venous disease in long-haul flights. HR is effective to control flight microangiopathy associated with edema.

Keywords

Microangiopathy Flights Airplanes Edema HR 0-(beta-hydroxyethyl)-rutosides Paroven Venoruton Laser doppler flowmetry Microcirculation Venous diseases Oxerutins

References

1. Geroulakos G , Hossain J , Tran T. Economy-class syndrome presenting as phlegmasia caerulea dolens. Eur J Vasc Endovasc Surg 2000;20:102-102.

2. Perry K. Blood clot kills woman after flight. Guardian 2001;23 Oct.

3. Homans J. Thrombosis of the deep leg veins due to prolonged sitting. N Engl J Med 1954;250:148-148.

4. Symington IS , Stack BHR . Pulmonary thromboembolism after travel. Br J Chest 1977;17:138-138.

5. Simpson K. Shelter deaths from pulmonary embolism. Lancet 1940;11:744-744.

6. Ferrari E , Chevallier T , Chapelier A , Baudouy M. Travel as a risk factor for venous thromboembolic disease: A case control study. Chest 1999;115:440-440.

7. Cruickshank JM , Gorlin R , Jennett B . Air travel and thrombotic episodes: The economy class syndrome. Lancet 1988;2:497-497.

8. Kraaijenhagen R , Haverkamp D , Koopman MMW , Prandoni P , Piovella F , Buller HR. Travel and risk of venous thrombosis. Lancet 2000;356:1492-1492.

9. Sarvesvaran R. Sudden natural deaths associated with commercial air travel. Med Sci Law 1986;26:35-35.

10.

10. Landgraf H , Vanselow B , Schulte-Huerman D , Mulmann MV , Bergan L. Economy class syndrome: Rheology fluid balance and lower leg oedema during a simulated 12-hour long-distance flight. Aviat Space Environ Med 1994;65: 930-930.

11.

11. AMA Commission on Emergency Services . Medical aspects of transportation aboard commercial aircraft. JAMA 1982;247:1007-1007.

12.

12. Gertler JP , Perry L , L'Italien G , et al. Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg 1993;18:939-939.

13.

13. Bendz B , Rostrup M , Sevre K , Andersen TO , Sandset PM. Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet 2000;356:1657-1657.

14.

14. Belcaro G , Geroulakos G , Nicolaides AN , Lennox A , Myers C , Winford M. Maladie veineuse thrombo-embolique apres vol aerien. Les etudes LONFLIT. Angeiologie 2001;53:17-17.

15.

15. Belcaro G , Geroulakos G , Nicolaides AN , Myers K , Winford M. Venous thromboembolism from air travel. The Lonflit Study. Angiology 2001;52:369-369.

16.

16. Cesarone MR , Belcaro G , Nicolaides AN , et al. Venous thromboembolism from air travel: The Lonflit3 study. Prevention with Aspiring vs low-molecular weight-heparin (LMWH) in high-risk subjects: A randomized trial. Angiology 2002;51:1-1.

17.

17. Belcaro G. Venous thrombosis and air-travel: Prevention with aspirin or low-molecular-weight-heparin. Circulation 2001;104:528-528.

18.

18. Belcaro G , Geroulakos G , Nicolaides AN , Cesarone MR , Bucci M , Lennox A . Prevention of deep venous thrombosis on long-haul flights. JAm Coll Cardiol 2002;39:212A-212A.

19.

19. Anonimous . Stockings, heparin found to eliminate “coach class” syndrome. American Heart Association Scientific Sessions Nov 14, 2001;8-8.

20.

20. Belcaro G , Rulo A , Candiani C . Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension with laser Doppler flowmetry, transcutaneous PO2 and Pco2 measurements, leg volumetry and ambulatory venous pressure measurements. Phlebology 1989;4:23-23.

21.

21. Cesarone MR , Ricci A , Belcaro G , Pomante P , Candiani C , Leon M , Nicolaides AN . Acute effect of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose-comparison study). Vasa 1992;21:76-76.

22.

22. Cesarone MR , Belcaro G , Geroulakos G , Griffin M , Lennox A , De Sanctis MT , Acerbi G. Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton;0-(beta-hydroxyethyl)-rutosides:a prospectiverandomised, controlled trial. J Cardiovasc Pharmacol Ther 2002;7:S17-S17.

23.

23. Belcaro G , Nicolaides AN , Veller M. Venous disorders: A manual of diagnosis and treatment. Cambridge, Saunders, 1996.

24.

24. Belcaro G , Nicolaides AN. Noninvasive investigations in vascular disease. London: Imperial College Press, 2001.

25.

25. Belcaro G , Nicolaides AN , Stansby G. The venous clinic. London: Imperial College Press, 1999.

26.

26. Belcaro G , Bollinger A , Hoffman U , Nicolaides AN. Laserdoppler. London: Med-Orion, 1995.

27.

27. Cesarone MR , Belcaro G , Nicolaides AN , Arkans E. The edema tester in the evaluation of swollen limbs in venous and lymphatic disease. Panmin Med 1999;41:10-10.

28.

28. Thulesius O. Chronic venous insufficiency and varicose veins physiopathological view points. Lakartidningen 1983;80(17):1791-1791.

29.

29. Data from USA Today, 2000.

30.

30. James J. Perils of passage. Time 2001:54-54.

31.

31. Eklof B. Report from the WHO meeting in Geneva, March 2001 (unpublished, manuscript in preparation). 32. Cesarone MR, Meli E. Volare con Sicurezza. Jet-leg. 11 problema dell'edema e della trombosi in voli di lunga durata. Ediz Minerva Medica Turin, 2001.

32.

33. Scurr JH , Machin SJ , Bayley S , Mackie IJ , Mc Donald S , Coleridge Smith PD. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 2001;357:1485-1485.

33.

34. Webster B. Airlines tell passengers to stretch legs. Times 2001; 12 Jan: 1-1.

34.

35. Geroulakos G. The risk of venous thromboembolism from air travel: The evidence is only circumstantial. Editorial. BMJ 2001;322:188-188.

35.

36. Nicolaides AN. Investigation of chronic venous insufficiency: A consensus statement. Circulation 2000;102:e126-e126.

36.

37. Slater AE. The European Union's Clinical Trials Directive.